Advertisement
Erratum| Volume 2, ISSUE 1, P111-112, February 2021

Download started.

Ok

Erratum

    Open AccessPublished:December 14, 2020DOI:https://doi.org/10.1016/j.hroo.2020.12.001
    Erratum
    Previous ArticleErratum
    Next ArticleEditorial Board
        Disclosure/disclaimer and/or guidelines/ethics statements were not included in the published version of the following articles that appeared in previous issues of Heart Rhythm O2.
        The appropriate disclosure/disclaimer and/or guidelines/ethics statements, provided by the Authors, are included below.
        • 1.
          “Atrial fibrillation detection from raw photoplethysmography waveforms: A deep learning application” [Heart Rhythm O2, 2020; 1 (1): 3-9] https://doi.org/10.1016/j.hroo.2020.02.002
          • Ethics/guidelines clarification: This study adhered to the guidelines set forth by the Office of Human Research Protection that is supported by U.S. Department of Health & Human Services.
        • 2.
          “Screening for atrial fibrillation in high-risk nursing home residents” [Heart Rhythm O2, 2020; 1 (1): 10-13] https://doi.org/10.1016/j.hroo.2020.02.003
          • Ethics/guidelines clarification: This study adhered to the guidelines set forth by the Office of Human Research Protection that is supported by U.S. Department of Health & Human Services.
        • 3.
          “Spatial relationship between the pulmonary trunk and the left coronaries: Systematic risk assessment based on automated three-dimensional distance measurements” [Heart Rhythm O2, 2020; 1 (1): 14-20] https://doi.org/10.1016/j.hroo.2020.02.001
          • Disclosures: The authors have no conflicts to disclose.
        • 4.
          “Wire countertraction for sheath placement through stenotic and tortuous veins: The “body flossing” technique” [Heart Rhythm O2, 2020; 1 (1): 21-26] https://doi.org/10.1016/j.hroo.2020.01.001
          • Disclosures: The authors have no conflicts to disclose.
          • Ethics/guidelines clarification: This registry was approved by our institutional review board. This study complied with the guidelines set forth in the Declaration of Helsinki.
        • 5.
          “A novel screening test for inappropriate shocks due to myopotentials from the subcutaneous implantable cardioverter–defibrillator” [Heart Rhythm O2, 2020; 1 (1): 27-34] https://doi.org/10.1016/j.hroo.2020.01.002
          • Ethics/guidelines clarification: This study complied with the guidelines set forth in the Declaration of Helsinki.
        • 6.
          “Review of mobile applications for the detection and management of atrial fibrillation” [Heart Rhythm O2, 2020; 1 (1): 35-43] https://doi.org/10.1016/j.hroo.2020.02.005
          • Disclosures: The authors have no conflicts of interest to disclose.
        • 7.
          “Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)” [Heart Rhythm O2, 2020; 1 (2): 77-82] https://doi.org/10.1016/j.hroo.2020.04.001
          • Ethics/guidelines clarification: This study complied with the guidelines set forth in the Declaration of Helsinki.
        • 8.
          “One size fits all, or do we have to rethink optimal programming in implantable cardioverter-defibrillators implanted for secondary prevention?” [Heart Rhythm O2, 2020; 1 (2): 83-84] https://doi.org/10.1016/j.hroo.2020.05.001
          • Disclosures: The authors have no conflicts of interest to disclose.
        • 9.
          “Left ventricular paced activation in cardiac resynchronization therapy patients with left bundle branch block and relationship to its electrical substrate” [Heart Rhythm O2, 2020; 1 (2): 85-95] https://doi.org/10.1016/j.hroo.2020.04.002
          • Ethics/guidelines clarification: This study complied with the guidelines set forth in the Declaration of Helsinki.
        • 10.
          “Bariatric surgery to aLleviate OCcurrence of Atrial Fibrillation Hospitalization—BLOC-AF” [Heart Rhythm O2, 2020; 1 (2): 96-102] https://doi.org/10.1016/j.hroo.2020.04.004
          • Disclosures: The authors have no conflicts of interest to disclose.
          • Ethics/guidelines clarification: Informed consent was waived due to the use of retrospective and de-identified data. This study adhered to the guidelines set forth by the Office of Human Research Protection that is supported by U.S. Department of Health & Human Services.
        • 11.
          “Introducing a novel catheter–tissue contact feedback feature in robotic navigated catheter ablation: Utility, feasibility, and safety” [Heart Rhythm O2, 2020; 1 (2): 103-110] https://doi.org/10.1016/j.hroo.2020.04.003
          • Disclosures: The authors have no conflicts of interest to disclose.
          • Ethics/guidelines clarification: Written, informed consent was obtained from each subject. This study complied with the guidelines set forth in the Declaration of Helsinki.
        • 12.
          “Novel beta-blocker pretreatment prevents alcohol-induced atrial fibrillation in a rat model” [Heart Rhythm O2, 2020; 1 (2): 120-125] https://doi.org/10.1016/j.hroo.2020.02.006
          • Disclosures: The authors have no conflicts of interest to disclose.
        • 13.
          “Chronic dantrolene treatment attenuates cardiac dysfunction and reduces atrial fibrillation inducibility in a rat myocardial infarction heart failure model” [Heart Rhythm O2, 2020; 1 (2): 126-135] https://doi.org/10.1016/j.hroo.2020.03.004
          • Disclosures: The authors have no conflicts of interest to disclose.
        • 14.
          “What goes in may need to come out: Considerations in the extraction of a lumenless, fixed-screw permanent pacemaker lead” [Heart Rhythm O2, 2020; 1 (2): 160-163] https://doi.org/10.1016/j.hroo.2020.04.007
          • Ethics clarification: The patient’s parents provided written, informed consent.
          • Disclaimer: Given her role as Associate Editor, Ulrika Birgersdotter-Green had no involvement in the peer review of this article and has no access to information regarding its peer review.
        • 15.
          “Assessing the perforation site of cardiac tamponade during radiofrequency catheter ablation using gas analysis of pericardial effusion” [Heart Rhythm O2, 2020; 1 (4): 268-274] https://doi.org/10.1016/j.hroo.2020.06.005
          • Ethics/guidelines clarification: This study complied with the guidelines set forth in the Declaration of Helsinki.

        Article info

        Publication history

        Published online: December 14, 2020

        Identification

        DOI: https://doi.org/10.1016/j.hroo.2020.12.001

        Copyright

        © 2020 Heart Rhythm Society. Published by Elsevier Inc.

        ScienceDirect

        Access this article on ScienceDirect

        Linked Article

        The content on this site is intended for healthcare professionals.


        We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
        Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


        RELX